Psych Trial Halted After Death; Curbing Phone Addiction; Most Worried Racial Group
The FDA halted patient enrollment in a phase III trial of evenamide in treatment-resistant schizophrenia following the sudden death of a participant, Newron Pharmaceuticals said. Magnetic seizure therapy achieved similar remission rates to electroconvulsive therapy in patients with bipolar depression, but was better tolerated and had less worsening of autobiographical memory, a randomized trial showed….
